Phase III study of JR-131 for the treatment of renal anemia
Latest Information Update: 04 Apr 2019
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Anaemia; Renal failure
- Focus Therapeutic Use
- Sponsors Kissei Pharmaceutical
- 05 Feb 2018 Status changed from recruiting to completed.
- 17 Jan 2018 Positive results of the study has been announced, according to a Kissei Pharmaceutical and JCR Pharmaceuticals media release.
- 19 Sep 2016 New trial record